104 related articles for article (PubMed ID: 15603307)
21. Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors.
Nieder C; Grosu AL; Stark S; Wiedenmann N; Busch R; Kneschaurek P; Molls M
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1055-9. PubMed ID: 16338100
[TBL] [Abstract][Full Text] [Related]
22. Effect of fractionation in stereotactic body radiation therapy using the linear quadratic model.
Yang J; Lamond J; Fowler J; Lanciano R; Feng J; Brady L
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):150-6. PubMed ID: 23245283
[TBL] [Abstract][Full Text] [Related]
23. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
24. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
25. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
26. Fractionated (split dose) radiosurgery in patients with recurrent brain metastases: implications for survival.
Davey P; Schwartz M; Scora D; Gardner S; O'Brien PF
Br J Neurosurg; 2007 Oct; 21(5):491-5. PubMed ID: 17852114
[TBL] [Abstract][Full Text] [Related]
27. Single-fraction stereotactic radiosurgery for intracranial targets.
Verhey LJ; Chen CC; Chapman P; Loeffler J; Curry WT
Neurosurg Clin N Am; 2006 Apr; 17(2):79-97, v. PubMed ID: 16793501
[TBL] [Abstract][Full Text] [Related]
28. [Stereotactic radiosurgery in the intracranial benign neoplasms and malignant tumors of the brain].
Mascarenhas F; Costa MS; Ortiz M; Almeida A; Carvalho H; Ferreira AG; Cattoni MB
Acta Med Port; 2005; 18(1):45-60. PubMed ID: 16202334
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases.
Lo SS; Chang EL; Suh JH
Expert Rev Neurother; 2005 Jul; 5(4):487-95. PubMed ID: 16026232
[TBL] [Abstract][Full Text] [Related]
30. The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice.
Nedzi LA
Semin Radiat Oncol; 2008 Oct; 18(4):265-72. PubMed ID: 18725114
[TBL] [Abstract][Full Text] [Related]
31. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).
Drzymala RE; Wasserman TH; Won M; Shaw E; Cmelak AJ; Loeffler J; Souhami L;
Radiother Oncol; 2008 Apr; 87(1):89-92. PubMed ID: 18342381
[TBL] [Abstract][Full Text] [Related]
32. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
Soisson ET; Tomé WA; Richards GM; Mehta MP
Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
Fowler JF
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
[TBL] [Abstract][Full Text] [Related]
34. Biological optimization of the dose in rectal carcinoma.
Valentini V; Morganti AG; Mantini G; Petrone A; Tagliaferri L; Gambacorta MA
Rays; 2004; 29(3):343-9. PubMed ID: 15603308
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic radiosurgery and radiation therapy for spinal tumors.
Lo SS; Chang EL; Yamada Y; Sloan AE; Suh JH; Mendel E
Expert Rev Neurother; 2007 Jan; 7(1):85-93. PubMed ID: 17187488
[TBL] [Abstract][Full Text] [Related]
36. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
Sharma SD; Jalali R; Phurailatpam RD; Gupta T
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy for primary and secondary brain tumors.
Brada M; Ross G
Curr Opin Oncol; 1995 May; 7(3):214-9. PubMed ID: 7654822
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery in patients with multiple brain metastases.
Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR
Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289
[TBL] [Abstract][Full Text] [Related]
39. Current role of radiation therapy in the management of malignant brain tumors.
Truong MT
Hematol Oncol Clin North Am; 2006 Apr; 20(2):431-53. PubMed ID: 16730301
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas.
Kano H; Niranjan A; Kondziolka D; Flickinger JC; Lunsford LD
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1333-9. PubMed ID: 18723295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
